| Brief |
Hesheng Biotechnology Co., Ltd. is a biotechnology company established by Dr. Li Hexin, the founder of Hesheng College of the Chinese University of Hong Kong, and a number of experts. We focus on the research and development and sales of diversified raw materials and health nutrition products, adhering to the scientific data, Rigorous attitude, unique raw materials, and providing safe and effective products to improve and maintain consumers' health.
Our mission:
1. Convey correct concepts of health and nutrition.
2. Provide systematic anti-aging cell nutrients.
3. Promote the popularization of functional medicine.
4. Help people improve their sub-health status.
R&D team:
We have a R&D team composed of doctors, nutritionists, food scientists and biochemical testing medical institutions, dedicated to the development of unique new medical cell nutrition raw materials and products; providing the latest and most effective health solutions to the market. Hesheng Biotechnology Co., Ltd. has a professional R&D center and a high-standard food factory.
Service introduction:
Raw material supply.
Formulation design.
OEM / ODM.
Education and training.
Product introduction:
1. Ten years of experience in producing four high-glycemic raw material products (Taiwan Medical Center’s human clinical DM reversal formula).
2. Female anti-aging and ovarian health raw material products (human clinical).
3. Male anti-aging raw materials and products (human clinical).
4. Probiotics, fish oil, nutritional supplements for the elderly and other raw material products.
Partners:
Establish accurate and professional product scientific data together with Qixin Clinic, a well-known testing institution in Taiwan for 41 years.
Medical institutions:
Cooperate with dozens of clinics across Taiwan in business related to diabetes, anti-attenuating lipids, and anti-aging markets.
Market size:
According to statistics from the Ministry of Health and Welfare, the number of people seeking medical treatment for diabetes will increase by 70,000 every year from 2018 to 2022.
The 2015 China National Nutrition and Health Survey estimates that 31.7% of men over 18 years old have prediabetes; 22.1% of women over 18 years old have prediabetes. The total is about 29.6%. This translates to nearly 5.9 million people who are in the prediabetes stage, which is a very large number. .
Goal outlook:
Hesheng Biotechnology Co., Ltd. will continue to expand its product line, enhance its influence, and strengthen its presence in the global market. Continue to uphold the business philosophy of "innovation, quality, and integrity" to bring health and happiness to more families.
Target market: Southeast Asian market, European and American market. |
